vScreenML 2.0 is an AI model developed by Fox Chase Cancer Center and Temple University School of Pharmacy (United States), first published in October 2024. It works in the biology domain, on tasks such as drug discovery.
Epoch AI has no training-compute estimate for this model.
Access: Unreleased. Its weights are not openly released. Epoch AI rates the confidence of this record as confident.